No Detail Found!

Technehum-99m methylene diphosphonate scintimammography for evaluation of palpable breast masses

Author(s)
ShoabShah Institute of Radiotherapy and Nuclear Medicine (IRNUM), Peshawar, Pakistan.
Mah Muneer Khan Khyber Teaching Hospital, Peshawar; Pakistan. “
Amjad Aziz Khan Multan Institute of Nuclear Medicine Radiotherapy (MINAR), Multan, Pakistan.
AakifUllah Khan Institute of Radiotherapy and Nuclear Medicine (IRNUM), Peshawar, Pakistan
Sher Mohammad Khan Institute of Radiotherapy and Nuclear Medicine (IRNUM), Peshawar, Pakistan
Abstract
To evaluate technetium-99m methylene diphosphonate (99mTc-MDP) as a noninvasive tumor-localizing agent in patients with palpable breast masses and to differentiate malignant from benign breast lesions. Design : It was an observational and experimental study. Place and Duration of Study: The study was conducted at the Institute of Radiotherapy and Nuclear Medicine (IRNUM), Peshawar during a six-month period (June to November, 1995). Subjects and Methods: 99mTc-MDP scintimammography (SMM) was performed in thirty patients with palpable breast masses (Group A). Ten patients with no palpable breast abnormality (Group B) also underwent "mTc-MDP breast study; they served as controls. Upright anterior, lateral and oblique lateral images of the breasts were acquired 10-30 minutes after intravenous injection of 740 MBq of 99mTc-MDR This was performed during routine bone scanning. SMM was followed by surgical and/or needle biopsy. Results: Breast cancer was histologically diagnosed in twenty-two (73%), and benign disease found in eight patients (27%). Of the twenty-two breast carcinomas, twenty (91 %) were detected using "mTc-MDP SMM, while no uptake was seen in two (9%). Of the eight patients with pathologically proven benign breast lesions, seven (88%) either did not show any uptake or showed faint bilateral accumulation. Focal 99mTc-MDP uptake was observed in one fibroadenoma. Conclusion: The study showed that SMM with "mTc-MDP is positive in a high percentage of patients with carcinoma of the breast and may differentiate malignant from benign masses
Publication Details
Page(s) 23-27
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 12, Issue: 1, Year: 2002

Request the full text from PASTIC

Keywords
biological, Tumor markers, Breast neoplasm, Technitium To 99m Medronate
References
. .Determiwneheth9e9mrTc-MDPscintimammogrcaopuhlyd drawonnthenormablreasttodefintehebackgrouTnudm.or beusedtodifferentmiaatleignafnrotmbenigmnasses. tobackgro u(Tn/Bd) ratiowsertehendetermined. , : .
.1975 .GleischmanSH, etalThalliumscintigraphiny phatesas an indicatoorf breasptathologyJN. udMed theevaluatioonf mass abnormalitieosf thebreast, 34 : 18-23.
Kao CH,Wang SJ,Liu TJ .1994 .The use of technetium-99m methoxyisobutylisonitbrrileeasstcintigraphtyoeval­u atepalpablbereasmtasses. EurJNudMed, 21 : 432-6.
.1997 .Scintimammographwyith 99mTc-MDP in thedetectionof primarybreastcancer. Q J Nud Med, 41 : 225-30.
- ,Lee JK,Kao CH,Sun SS .1995 .Technetium-99mmethylene mammographtyoimage primarybreasctancerJ. OncolRep, 6 : 659-63.
Mena I,Diggles L .1993 .-99m-MDP niquesforthediagnosisof breastcancera: new role in primaryamyloidosiwsitha reviewof mechanisms of pronescintimammographuysing technetium-99m of softtissuelocalizatiofnboneseeking radioph­ar sestamibiE. udMed, 34 : 1612-5.
Memis A,Y A .2000 .The comparisonof dualphase99mTc-MIBI and 99mTc-MIBI: a comparativsetudywith mammography 99mTc-MDP scintimammographiny theevaluatioonf andultrasonograpNhuyd. asses:preliminarryeportA.nn Nud Med, 15 : 3e9a-4s6tm.
Lu G,Huang HY,Sun Q,Liu YH,Rezai K. .1995 ."mTc-MDP: a potentiafolrfalsepositiv einterpretation. 150-6. Nud Med Commun, 18 : 208-9.
Taillefer R.,Gray HW .1999 .Bone scanningin clinicaplractice. diagnosis.Semin NudMed, 29 : 211-35.
.1999 .-99mbonescansaremore 99mTc- MDP scintimammographinypalpablaend nonsensitivethan1-123-MIBG scansforboneimaging in palpablebreastlesions:comparisonwith mammoneuroblastomJNau. AnticancerRes, 19 : 3601-6.
.1993 .! 99Tcm-sestamibsicintimammography in patientswith suspiciousbreastlesions:compar­i. diphosphonatbey a pulmonaryhamartoma/ 26, 66 : 74-6.
.1997 .Potsaid sonof SPET andplanairmagesin thedetectioonf pr­i MS. Technetium-99m-diphosphonactoencentratioinn marytumoursand axillarlyymphnodeinvolvement. NudMedCommun, 18 : 839-45.
McDougall IR,Aziz A,Hashmi R,Ogawa Y,HayashiK. Y .1999 .-MIBI diphosphonatien breasttissue. PET versusplanarimaging. 655-7. CancerBiotherRadiopharm, 14 : 495-500.
0

Citations

0

Downloads

75

Views